Cell Division is an open access, peer-reviewed journal, which publishes articles in areas including, but not limited to, molecular aspects of cell cycle control and cancer, cell growth, proliferation, survival, differentiation, signalling, gene transcription, protein synthesis, genome integrity, chromosome stability, centrosome duplication, DNA damage and DNA repair.
Featured Article: Detection of early relapse in multiple myeloma patients
Multiple myeloma remains a hard to treat disease, as almost all patients relapse. It is currently not possible to predict when relapse will occur, but studies suggest that microRNAs could be good markers of relapse.
Public domain image from https://commons.wikimedia.org/wiki/File:Multiple_myeloma_(1)_MG_stain.jpg
Articles
-
-
The m6A modification of LncRNA LINC00200 regulated by WTAP accelerates glioma tumorigenesis by regulating Wnt/β-catenin pathway
-
METTL16/IGF2BP2 axis enhances malignant progression and DDP resistance through up-regulating COL4A1 by mediating the m6A methylation modification of LAMA4 in hepatocellular carcinoma
-
YAP1 activates SLC2A1 transcription and augments the malignant behavior of colorectal cancer cells by activating the Wnt/β-catenin signaling pathway
-
RFX2 downregulates RASSF1 expression and YAP phosphorylation through Hippo signaling to promote immune escape in lung adenocarcinoma
Call for Papers: New Biomarkers of Solid and Hematological Malignancies
Cell Division is calling for submissions to our Collection on New Biomarkers of Solid and Hematological Malignancies. This Collection focuses on the latest discoveries of biomarkers in both solid and hematological malignancies, aiming to highlight their potential in improving cancer diagnosis, prognosis, and personalized therapy.
Read MoreAims and scope
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.8
5-year Journal Impact Factor: 3.1
Source Normalized Impact per Paper (SNIP): 0.965
SCImago Journal Rank (SJR): 1.284Speed 2024
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 128Usage 2024
Downloads: 179,933
Altmetric mentions: 38